Maimed Polskasp. z o.o.
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2005-12-30
Share capital
50 000,00 PLN
Registered address
ul. Romualda Traugutta 21, 42-690 Boruszowice, Poland
Electronic delivery address
AE:PL-65294-17749-GWDHE-29
Financials
Revenue history (in k)
Filing timeliness
2 of 6 financial statements were filed late (the longest delay 726 days for 2022), 1 not filed.
- 202526/06/2026
- 202410/07/2025
- 202310/07/2025
- 202210/07/2025
- 2021not filed
- 202005/07/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 364.33kMedianUSD 917.74kAverageUSD 25.73m
Net profit
This companyUSD 46.99kMedianUSD 14.44kAverageUSD 2.75m
Operating costs
This companyUSD 314.93kMedianUSD 860.03kAverageUSD 21.34m
Assets
This companyUSD 71.77kMedianUSD 883.09kAverageUSD 31.39m
Industry
Authorized Representatives
Albert Adrianek – President of the Management Board
Dirk Pfemfert – Ii Wiceprezes Zarządu
Manner of representation
Each member of the management board is authorized to represent the company and make declarations on its behalf independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Albert Adrianekage 45 | 350 | – | 35% |
Maimed Gmbh | 650 | – | 65% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2005-09-01.
71 1750 1237 0000 0000 2118 5857
47 1560 0013 0000 1140 0005 5458
40 1750 1237 0000 0000 2118 5833
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jan 12, 2024 | Dissolution without liquidation opened |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Mar 9, 2021 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $2,358$2,358 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Mar 9, 2021 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $2,263$2,263 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Mar 9, 2021 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $2,135$2,135 | Prezes Zakładu Ubezpieczeń Społecznych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| DR Andresp. z o.o. | $453,987.42 | drandre.pl | ||
| STEM Cells SpinS.A. | $287,714.76 | stemcellsspin.com.pl | ||
| F1 PharmaS.A. | $272,113.66 | f1pharma.pl | ||
| Ti-Comsp. z o.o. | $157,549.77 | ticomglobal.com | ||
| LideoS.A. | $95,067.91 | lideo.tech | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| BIO Animalisp. z o.o. | $49,176.96 | proanimali.com | ||
| Ampliconsp. z o.o. | $48,330.99 | amplicon.pl | ||
| Xenira Pharmaceuticalssp. z o.o. | $26,670.82 | xenirapharma.com | ||
| Sanford Biotechsp. z o.o. | $2,586.64 | sanfordbiotech.com |
Change history
| Date | Event | |
|---|---|---|
| 2015-09-03 | Address change (Nakielska 35, 42-600, Tarnowskie Góry → Ul. Romualda Traugutta 21, 42-690, Boruszowice) | |
| 2014-03-20 | PKD change (Removed: 24.42.Z, 33.10.A, 33.10.B, 51.46.Z, 51.47.Z, 51.90.Z, 52.12.Z, 52.31.Z, 52.32.Z, 52.33.Z, 52.48.G, 70.12.Z, 70.20.Z, 74.82.Z; Added: 21.20.Z, 26.60.Z, 32.50.Z, 33.14.Z, 33.20.Z, 46.46.Z, 46.49.Z, 46.90.Z, 47.19.Z, 47.73.Z, 47.74.Z, 47.75.Z, 47.78.Z, 68.10.Z, 68.20.Z, 82.92.Z) | |
| 2005-12-30 | Entered in the register |
FAQ
The company was registered in the Polish National Court Register (KRS) on December 30, 2005.
The headquarters is located at: ul. Romualda Traugutta 21, 42-690 Boruszowice.
The share capital of the company is PLN 50,000 (approx. $13,506).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
In 2024, the company generated total revenue of $452,954, representing a decrease of 15.8% compared to 2023.
No, the company recorded a net loss of $16,384 in 2024.
The largest operating cost category falls under other operating costs. This category amounted to $405,332 in 2024, representing 87% of all operating expenses.
Last updated: 2026-07-15